Inward Investment

Inward Investment News

View news from other Pharmaceutical sectors:
151-165 of 421 results
Rusnano co-invests in Selecta, Bind for drug development in Russia
By PBR Staff Writer
Rusnano of Russia has invested $50m in Bind Biosciences and Selecta Biosciences in financing rounds amounting to $94.5m to develop nanomedicine-based drugs.
Inward Investment > News
Celesio acquires stake in Brazilian pharma firm
By PBR Staff Writer
Celesio, a German service provider for pharmaceutical and healthcare markets, has acquired 60% of Oncoprod Group, a Brazilian wholesaler for specialty pharmaceuticals.
Inward Investment > News
EvaluatePharma expands to Japan
By PBR Staff Writer
EvaluatePharma, a UK based research firm, has expanded its business with the establishment of EvaluatePharma Japan KK.
Inward Investment > News
Covidien to establish new R&D center in China
By PBR Staff Writer
Covidien, a US based healthcare products provider, is set to establish a new research and development center in Shanghai, China.
Inward Investment > News
Human Stem Cell Institute, Xenetic partner to invest in biotech sector
By PBR Staff Writer
Human Stem Cell Institute and Xenetic Biosciences have entered into collaboration to invest in the international biotech sector.
Inward Investment > News
Aurobindo, OJSC Diod form JV in Russia
By PBR Staff Writer
Aurobindo Pharma and OJSC Diod have set up a new joint venture in Russia with 50-50 partnership, through their investment holding subsidiaries.
Inward Investment > News
Usana to expand operations into France, Belgium
By PBR Staff Writer
Usana Health Sciences, a developer and manufacturer of nutritional, personal care and weight-management products, has unveiled plans to expand its operations into France and Belgium in the first quarter of 2012.
Inward Investment > News
Eisai sets up new subsidiary in Mexico
By PBR Staff Writer
Eisai has expanded its sales operations in Mexico by establishing a new sales subsidiary Eisai Laboratorios to introduce its products covering central nervous system diseases and oncology.
Inward Investment > News
Kadrige inaugurates new office in US
By PBR Staff Writer
French software-as-a-service (SaaS) e-detailing and e-conferencing solutions provider Kadrige has opened a new office in the US to ramp up its international development plan in the North American region.
Inward Investment > News
Daiichi Sankyo, Ranbaxy to widen Hybrid Business Model in Mexico
By PBR Staff Writer
Daiichi Sankyo and Ranbaxy Laboratories are set to widen their Hybrid Business Model with the launch of Olmesartan medoxomil in Mexico.
Inward Investment > News
Fujifilm, Dr Reddy's to establish JV company in Japan
By PBR Staff Writer
Fujifilm and Indian drug maker Dr Reddy's have inked a Memorandum of Understanding (MoU) for establishing a joint venture in Japan.
Inward Investment > News
Life Technologies establishes IDC in India
By PBR Staff Writer
US based global biotechnology firm Life Technologies has established an Indian regional distribution hub in Bangalore to strengthen its business in South Asian region.
Inward Investment > News
Roche establihes R&D institute in France
By PBR Staff Writer
Roche has established a new research and development (R&D) institute in France under the lead of the company’s pharma research and early development (pRED) unit.
Inward Investment > News
Pfizer to retain presence on Sandwich site
By PBR Staff Writer
Pfizer has decided to retain research and development operations at Sandwich site in Kent which will secure 350 jobs in pharmaceutical science.
Inward Investment > News
ClinTec widens presence in Asia Pacific region
By PBR Staff Writer
ClinTec, a global contract clinical research organization, has established new offices in China, Singapore and Thailand to strengthen its presence in Asia Pacific (APAC) region.
Inward Investment > News
151-165 of 421 results